Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Eliza, Atkinson"'
Publikováno v:
Microbial Cell Factories, Vol 21, Iss 1, Pp 1-12 (2022)
Abstract Background Low-cost sustainable feedstocks are essential for commercially viable biotechnologies. These feedstocks, often derived from plant or food waste, contain a multitude of different complex biomolecules which require multiple enzymes
Externí odkaz:
https://doaj.org/article/4eed50b661214e13b52f7c46ecdc2172
Publikováno v:
Principles in Microbiome Engineering. :195-218
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9b94b76a25e85b896824b8df990adef
https://doi.org/10.1002/9783527825462.ch7
https://doi.org/10.1002/9783527825462.ch7
Autor:
Farshad Darvishi, Sajad Rafatiyan, Mohammad Hossein Abbaspour Motlagh Moghaddam, Eliza Atkinson, Rodrigo Ledesma-Amaro
The application of microbial consortia is a new approach in synthetic biology. Synthetic yeast consortia, simple or complex synthetic mixed cultures, have been used for the production of various metabolites. Cooperation between the members of a conso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aea4e60b228cd22713f712fe07d12664
http://hdl.handle.net/10044/1/99857
http://hdl.handle.net/10044/1/99857
Background Low-cost sustainable feedstocks are essential for commercially viable biotechnologies. These feedstocks, often derived from plant or food waste, contain a multitude of different complex biomolecules which require multiple enzymes to hydrol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54c4b28bb35be3f2d5136c83fc43f694
http://hdl.handle.net/10044/1/97590
http://hdl.handle.net/10044/1/97590
In natural ecosystems, microorganisms live in communities where each member interacts with the others and with the environment to efficiently utilise available resources. Division of Labor (DOL) is an evolutionary strategy that evolved by microbial c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15565a59e71698031c8ac8948eb2f733
http://hdl.handle.net/10044/1/95999
http://hdl.handle.net/10044/1/95999
Selective FGFR inhibitors such as infigratinib (BGJ398) and erdafitinib (JNJ-42756493) have been evaluated in clinical trials for cancers with FGFR3 molecular alterations, particularly in urothelial carcinoma patients. However, a substantial proporti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fc59bf67308d035ecaf4a391a05f62f
https://doi.org/10.1101/2020.04.04.025544
https://doi.org/10.1101/2020.04.04.025544
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 9
International Journal of Molecular Sciences, Vol 21, Iss 3214, p 3214 (2020)
Volume 21
Issue 9
International Journal of Molecular Sciences, Vol 21, Iss 3214, p 3214 (2020)
Selective FGFR inhibitors such as infigratinib (BGJ398) and erdafitinib (JNJ-42756493) have been evaluated in clinical trials for cancers with FGFR3 molecular alterations, particularly in urothelial carcinoma patients. However, a substantial proporti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fde9801e3b2d0501413edfcd1052000
https://pubmed.ncbi.nlm.nih.gov/32370101
https://pubmed.ncbi.nlm.nih.gov/32370101